AVEO Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AVEO Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 546% to $38,874,000. Profit margin reached -157%. Total operating expenses were $87,112,000.
Profit Margin
| 2012 | 19.28M | -114.39M | -593.15% |
|---|---|---|---|
| 2013 | 1.29M | -107.02M | -8277.57% |
| 2014 | 18.12M | -52.73M | -291.01% |
| 2015 | 19.02M | -15.00M | -78.85% |
| 2016 | 2.51M | -26.88M | -1069.07% |
| 2017 | 7.57M | -65.02M | -857.96% |
| 2018 | 5.40M | -5.32M | -98.52% |
| 2019 | 28.79M | 9.38M | 32.6% |
| 2020 | 6.01M | -35.58M | -591.19% |
| 2021 | 38.87M | -61.17M | -157.37% |
AVEO Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 38.87M | 6.01M | 28.79M | 5.40M | 7.57M | 2.51M | 19.02M | 18.12M | 1.29M | 19.28M |
Cost of revenue | 4.73M | 1.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 34.13M | 4.77M | 28.79M | 5.40M | 7.57M | 2.51M | 19.02M | 18.12M | 1.29M | 0 |
Operating exp. | ||||||||||
Research and development | 26.29M | 22.67M | 17.95M | 20.65M | 25.17M | 23.70M | 12.87M | 38.25M | 68.46M | 91.35M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 87.11M | 44.89M | 29.16M | 31.43M | 34.31M | 31.90M | 27.09M | 56.84M | 97.18M | 128.29M |
Operating income | -49.55M | -38.87M | -374K | -25.35M | -28.81M | -29.39M | -12.42M | -50.44M | -103.90M | -111.63M |
Other income (expenses), net | -3.78M | 3.29M | 9.76M | 20.02M | -36.11M | 2.60M | -2.57M | -2.29M | -3.12M | -2.75M |
Income before tax | -53.34M | -35.58M | 9.38M | -5.32M | -64.92M | -26.78M | -15.00M | -52.73M | -107.02M | -114.39M |
Income tax expense | 7.83M | 4.89M | 0 | 0 | 101K | 101K | -268K | 98K | 2K | 0 |
Net income | -61.17M | -35.58M | 9.38M | -5.32M | -65.02M | -26.88M | -15.00M | -52.73M | -107.02M | -114.39M |
Earnings per share | ||||||||||
Basic EPS | -2.86 | -1.66 | 0.61 | -0.41 | -6.14 | -3.88 | -2.69 | -10.09 | -21.02 | -26.4 |
Diluted EPS | -2.86 | -1.66 | 0.61 | -0.41 | -6.14 | -3.88 | -2.69 | -10.09 | -21.02 | -26.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |